Elutia (ELUT) Share-based Compensation Growth (1y) (2021 - 2026)
Powered by 
Analysis
Elutia (ELUT) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.79 Bn | 175.19 Bn | 7.27 Bn | 18.31% |
| 2 | Intuitive Surgical | 127.05 Bn | 121.83 Bn | 1.96 Bn | 314.20% |
| 3 | Medtronic | 117.00 Bn | 108.18 Bn | 6.34 Bn | 45.35% |
| 4 | Stryker | 103.78 Bn | 100.31 Bn | 4.50 Bn | -78.13% |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | -15.28% |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 12.53% |
| 7 | Alcon | 32.98 Bn | 31.52 Bn | 1.68 Bn | 10.53% |
| 8 | Dexcom | 32.05 Bn | 30.10 Bn | 830.00 Mn | -13.91% |
| 9 | Steris | 20.68 Bn | 20.19 Bn | 684.20 Mn | 7.56% |
| 10 | Elutia | 36.01 Mn | 16.11 Mn | 1.45 Mn | 90.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.60% |
| Mar 31, 2026 | 94.28% |
| Dec 31, 2025 | -27.81% |
| Sep 30, 2025 | 9.33% |
| Jun 30, 2025 | 9.18% |
| Mar 31, 2025 | 4.38% |
| Dec 31, 2024 | 168.44% |
| Sep 30, 2024 | 96.00% |
| Jun 30, 2024 | 94.32% |
| Mar 31, 2024 | 95.54% |
| Dec 31, 2023 | -41.86% |
| Sep 30, 2023 | -6.11% |
| Jun 30, 2023 | -29.69% |
| Mar 31, 2023 | 42.07% |
| Dec 31, 2022 | -20.45% |
| Sep 30, 2022 | 75.72% |
| Jun 30, 2022 | 167.82% |
| Mar 31, 2022 | 63.22% |
| Sep 30, 2021 | 1,593.22% |
| Jun 30, 2021 | 1,129.17% |